| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
800 |
390 |
$197K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
3,947 |
2,235 |
$152K |
| J9035 |
Injection, bevacizumab, 10 mg |
1,959 |
1,278 |
$77K |
| 92134 |
|
4,613 |
3,560 |
$42K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,189 |
985 |
$26K |
| 92235 |
|
986 |
597 |
$21K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
839 |
647 |
$4K |
| 92202 |
|
302 |
215 |
$2K |
| 92226 |
|
411 |
162 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
37 |
27 |
$834.45 |
| 92225 |
|
78 |
26 |
$560.00 |
| 92250 |
|
838 |
517 |
$230.54 |
| 92201 |
|
19 |
16 |
$179.40 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18 |
15 |
$63.95 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
200 |
161 |
$0.00 |
| 1036F |
|
550 |
471 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
212 |
180 |
$0.00 |
| 4177F |
|
18 |
12 |
$0.00 |
| 2022F |
|
42 |
38 |
$0.00 |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
17 |
13 |
$0.00 |